01/17/2011
Nearly 90% of women who get breast cancer have NO strong family history. OncoVue is a simple saliva test done that is reimbursed by most insurance plans. Ask your doctor if OncoVue is right for you.
Cancer Risk Assessment
Share
Cancer Risk Assessment is a provider of OncoVue, the new genetic-based breast cancer risk assessment test.
OncoVue is a powerful tool to assess a woman's genetic risk for breast cancer. The OncoVue® breast cancer risk test is a result of research focused on understanding the role that multiple single nucleotide polymorphisms (SNPs) along with personal history measures contribute to a woman’s risk of developing breast cancer at various stages in her life. Oncovue is a simple saliva test covered by most insurance plans.
01/17/2011
01/17/2011
Early detection is the key to breast cancer survival. OncoVue results enable you to understand your individual risk of developing breast cancer by analyzing your DNA together with family history and personal lifestyle factors.
01/17/2011
"OncoVue®...One simple test. A lifetime of knowledge."
01/17/2011
When we speak of cancer, we should all be aware that there is "no zero-risk": all women are at some level of risk for breast cancer and our company is providing a very important and time critical opportunity to mitigate the devastating effects of an all too common disease as breast cancer.
01/17/2011
OncoVue is a genetic-based, breast cancer risk test that is relevent to all women, regardless of family history.
Want your school to be the top-listed School/college in New York?
Click here to claim your Sponsored Listing.
Click here to claim your Sponsored Listing.
Location
Contact the school
Telephone
Address
New York, NY
10019